Schlieren (Zurich), Switzerland, April 21, 2022 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that its MagnetOs Flex Matrix has been cleared by the U.S. Food and Drug Administration (FDA) as a bone void filler for use in the posterolateral spine.
MagnetOs Flex Matrix is a new open matrix bone graft with a unique fibrillar and flexible structure that optimizes the effect of Kuros’ established pro-healing NeedleGripTM surface technology for more predictable fusion. U.S. spine surgeons routinely mix their bone graft of choice with bone marrow aspirate and the MagnetOs Flex Matrix allows them to reap the benefits of MagnetOs’ NeedleGripTM surface technology while continuing with their routine perioperative practice.
BSD Robotics is proud to share a recent study conducted by SNP Biotechnology R&D Ltd “A new line method; A direct test in spinal muscular atrophy screening for DBS” now published in the journal of Molecular Genetics and Genomic Medicine. Given spinal muscular atrophy (SMA) is one of the most prevalent genetic disorders affecting young children and a major cause of death in infancy, the importance of research in this area is paramount.
SNP Biotechnology has developed the new line method (NLM) as a...
Caira Surgical, the pioneer in radar surgical tracking for navigated and robotic joint replacement surgery, announced today that Jon Greenwald, Chief Executive Officer, and Irina Benimovich, Chief Financial Officer, will conduct investor meetings and host presentations at the upcoming CG 2023 Musculoskeletal Conference and LSI USA `23 partnering event. March 7 – CG 2023 Musculoskeletal Conference
Ahead of the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting March 8-10, 2023, in Las...
Patent provides protection for High Frequency Spinal Cord Stimulation with Beat Technology
Vancouver, Washington – March 20, 2015 – Meagan Medical Inc., a clinical research and medical device development company focused on investigating and developing optimal ways of managing and controlling pain, announced today the issuance of a key patent related to a unique way of stimulating the spinal cord.
U.S. Patent No. 8,977,363 includes multiple system claims for delivering high frequency stimulation to...
Europe-wide aid project for the protection of people with paraplegiaCologne, 28/05/2020 – COVID-19 can be particularly dangerous for people with severe spinal cord injuries. That is why FARCO-PHARMA supports the European Spinal Cord Injury Federation (ESCIF) and the Association of Paraplegics in Germany e.V. (FGQ) with the supply of free protective masks for the caregivers of this sensitive group.People with severe spinal cord injuries are more likely to suffer from a severe case of COVID-19, as their...
We are pleased to announce that “EngageABLE”, a project of ABLE Human Motion in collaboration with the dutch hospital Sint Maartenskliniek, has been awarded for funding by DIH-HERO. The goal of this project is to enhance the capabilities of the ABLE Exoskeleton to promote users’ motivation and faster learning. DIH-HERO is an independent platform that connects Digital Innovation Hubs across Europe to create a network in the healthcare robotics sector.
The major aim of this call is to stimulate...
Customer comments
No comments were found for Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences’s MagnetOs Flex Matrix Cleared by FDA for Spinal Indications. Be the first to comment!
